Cargando…

Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis

Demyelination of the central nervous system is a prominent pathological hallmark of multiple sclerosis and affects both white and grey matter. However, demyelinated white and grey matter exhibit clear pathological differences, most notably the presence or absence of inflammation and activated glial...

Descripción completa

Detalles Bibliográficos
Autores principales: van Wageningen, Thecla A., Gerrits, Emma, Brouwer, Nieske, Brevé, John J. P., Geurts, Jeroen J. G., Eggen, Bart J. L., Boddeke, H. W. G. M. (Erik), van Dam, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914505/
https://www.ncbi.nlm.nih.gov/pubmed/35282162
http://dx.doi.org/10.1093/braincomms/fcac005
_version_ 1784667723523948544
author van Wageningen, Thecla A.
Gerrits, Emma
Brouwer, Nieske
Brevé, John J. P.
Geurts, Jeroen J. G.
Eggen, Bart J. L.
Boddeke, H. W. G. M. (Erik)
van Dam, Anne-Marie
author_facet van Wageningen, Thecla A.
Gerrits, Emma
Brouwer, Nieske
Brevé, John J. P.
Geurts, Jeroen J. G.
Eggen, Bart J. L.
Boddeke, H. W. G. M. (Erik)
van Dam, Anne-Marie
author_sort van Wageningen, Thecla A.
collection PubMed
description Demyelination of the central nervous system is a prominent pathological hallmark of multiple sclerosis and affects both white and grey matter. However, demyelinated white and grey matter exhibit clear pathological differences, most notably the presence or absence of inflammation and activated glial cells in white and grey matter, respectively. In order to gain more insight into the differential pathology of demyelinated white and grey matter areas, we micro-dissected neighbouring white and grey matter demyelinated areas as well as normal-appearing matter from leucocortical lesions of human post-mortem material and used these samples for RNA sequencing. Our data show that even neighbouring demyelinated white and grey matter of the same leucocortical have a distinct gene expression profile and cellular composition. We propose that, based on their distinct expression profile, pathological processes in neighbouring white and grey matter are likely different which could have implications for the efficacy of treating grey matter lesions with current anti-inflammatory-based multiple sclerosis drugs.
format Online
Article
Text
id pubmed-8914505
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89145052022-03-11 Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis van Wageningen, Thecla A. Gerrits, Emma Brouwer, Nieske Brevé, John J. P. Geurts, Jeroen J. G. Eggen, Bart J. L. Boddeke, H. W. G. M. (Erik) van Dam, Anne-Marie Brain Commun Original Article Demyelination of the central nervous system is a prominent pathological hallmark of multiple sclerosis and affects both white and grey matter. However, demyelinated white and grey matter exhibit clear pathological differences, most notably the presence or absence of inflammation and activated glial cells in white and grey matter, respectively. In order to gain more insight into the differential pathology of demyelinated white and grey matter areas, we micro-dissected neighbouring white and grey matter demyelinated areas as well as normal-appearing matter from leucocortical lesions of human post-mortem material and used these samples for RNA sequencing. Our data show that even neighbouring demyelinated white and grey matter of the same leucocortical have a distinct gene expression profile and cellular composition. We propose that, based on their distinct expression profile, pathological processes in neighbouring white and grey matter are likely different which could have implications for the efficacy of treating grey matter lesions with current anti-inflammatory-based multiple sclerosis drugs. Oxford University Press 2022-01-17 /pmc/articles/PMC8914505/ /pubmed/35282162 http://dx.doi.org/10.1093/braincomms/fcac005 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
van Wageningen, Thecla A.
Gerrits, Emma
Brouwer, Nieske
Brevé, John J. P.
Geurts, Jeroen J. G.
Eggen, Bart J. L.
Boddeke, H. W. G. M. (Erik)
van Dam, Anne-Marie
Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis
title Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis
title_full Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis
title_fullStr Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis
title_full_unstemmed Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis
title_short Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis
title_sort distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914505/
https://www.ncbi.nlm.nih.gov/pubmed/35282162
http://dx.doi.org/10.1093/braincomms/fcac005
work_keys_str_mv AT vanwageningentheclaa distinctgeneexpressionindemyelinatedwhiteandgreymatterareasofpatientswithmultiplesclerosis
AT gerritsemma distinctgeneexpressionindemyelinatedwhiteandgreymatterareasofpatientswithmultiplesclerosis
AT brouwernieske distinctgeneexpressionindemyelinatedwhiteandgreymatterareasofpatientswithmultiplesclerosis
AT brevejohnjp distinctgeneexpressionindemyelinatedwhiteandgreymatterareasofpatientswithmultiplesclerosis
AT geurtsjeroenjg distinctgeneexpressionindemyelinatedwhiteandgreymatterareasofpatientswithmultiplesclerosis
AT eggenbartjl distinctgeneexpressionindemyelinatedwhiteandgreymatterareasofpatientswithmultiplesclerosis
AT boddekehwgmerik distinctgeneexpressionindemyelinatedwhiteandgreymatterareasofpatientswithmultiplesclerosis
AT vandamannemarie distinctgeneexpressionindemyelinatedwhiteandgreymatterareasofpatientswithmultiplesclerosis